As it tries to pump more new drugs out of a smaller R&D operation, Pfizer is seeking to attract external research partners by giving up some control over drug discovery.
The government recently issued draft rules for a major area of health reform, outlining how accountable care organizations (ACOs) can work. Could the sunshine provisions be up next?
Medical/surgical journals are on the rebound, having posted a nascent recovery last year. Marc Iskowitz finds which categories and brands attracted the most ad dollars in 2010
The number of people with diabetes is on the rise. Marc Iskowitz examines drugmakers’ efforts to control this public health issue, the marketing of diabetes and why drug development for one of its leading causes has stumbled
Can Vermont bar companies from mining doctors’ prescribing data and selling it to drug makers, unless doctors consent, or does such a law violate the First Amendment?
J&J cleaves McNeil from consumer in move to restore OTC brands